May 2024 | Volume 20, Issue 4

Notable and Newsworthy




Dr. Sarah McAchran has completed the American Urological Association (AUA) Leadership Program and graduated at this year's annual meeting in San Antonio, TX. The AUA Leadership Program is designed for urologists who have demonstrated leadership skills within organized medicine and who wish to further develop these skills to become the AUA leaders of tomorrow. This highly competitive program selects applicants from each AUA section to participate in the year-long program.


Dr. David Jarrard has been selected to receive the UW Health Leadership Physician Excellence Award. This honor is given to a physician with significant and measurable contributions to UW Health and leadership excellence outside of the physician's department. The UW Health Physician Excellence Awards recognize our institution's most dedicated physicians, who demonstrate exceptional skills and a commitment to the mission, vision, and values of UW Health.



Dr. Shannon Cannon has been appointed to the Wisconsin Medical Alumni Association's Board of Directors. This is a three year term ending in June of 2027. We look forward to Dr. Cannon stepping into this role and supporting our alumni, students, residents, and the School.



Dr. Walid Farhat and colleagues recently had their article "Puberty Blocker, Leuprolide, Reduces Sex Differences in Rough-and-Tumble Play and Anxiety-like Behavior in Juvenile Rats" published in the Journal of Endocrinology. You can read the article here.

Pioneering Bladder Cancer Research in Humans and their Canine Companions

Urologic oncologist Kyle Richards, MD, FACS, of the Department of Urology at the UW School of Medicine and Public Health and Lauren Trepanier, DVM, PhD, DACVIM (SAIM), of the UW School of Veterinary Medicine, are collaborating on a groundbreaking research study titled "Non-Tobacco, Non-Occupational Chemical Exposures and Bladder Cancer Risk across Socioeconomic Strata." Using a novel, dual-species approach, Drs. Richards and Trepanier are examining environmental exposures in both humans and dogs to two chemicals, acrolein and inorganic arsenic, to learn if there is an association between those exposures and bladder cancer risk.


Continue reading

Diversity of Thought on Age When Treating Patients: Getting Beyond the Number

By Kyle A. Richards, MD, FACS (published in AUANews)


Ageism is a bias or discrimination toward an individual or group based on their biologic age. I met Sally in August of 2019 when she was 95 years young. She was a new patient added on to my clinic with a chief complaint of "new bladder mass," and I could not help but notice her age as I bustled into the procedure suite. I had been in practice for about 5 years at that time, and she was the oldest patient I could remember seeing in my clinic. I also remember thinking, please let this be a small tumor! Unfortunately, it was a large muscle invasive bladder cancer taking up the entire left side of her bladder and causing moderate amounts of blood in her urine. As she hopped off the cystoscopy table we began to talk, and I quickly learned what a remarkable woman she was.


Continue reading at AUANews

Facebook  Twitter